SBAC vs TCRX · P/E 30, rev $719.6M vs rev $2.0M
SBA Communications Corp (SBAC) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported SBAC revenue for 2025-12-31 was $719.6M. Net income was $370.3M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
SBAC currently screens at market cap $24.58B and trailing P/E 30.3. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the SBAC and TCRX stock pages for the full models.
Not investment advice.